Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma

被引:17
|
作者
Liu, Ken [1 ,2 ,3 ,7 ]
Dennis, Claude [1 ]
Prince, David S. [4 ]
Marsh-Wakefield, Felix [3 ,5 ]
Santhakumar, Cositha [1 ,3 ,5 ]
Gamble, Jennifer R. [6 ]
Strasser, Simone I. [1 ,2 ]
McCaughan, Geoffrey W. [1 ,2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Australian Natl Liver Transplant Unit, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Centenary Inst, Liver Injury & Canc Program, Sydney, NSW, Australia
[4] Liverpool Hosp, Dept Gastroenterol, Sydney, NSW, Australia
[5] Univ Sydney, Human Immunol Lab, Sydney, NSW, Australia
[6] Centenary Inst, Ctr Endothelium, Vasc Biol Program, Sydney, NSW, Australia
[7] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Level 9,Missenden Rd, Camperdown, NSW 2050, Australia
关键词
Vessels that encapsulate tumour clusters (VETC); angiogenesis; biomarker; metastasis; liver transplantation; epithelial mesenchymal transition (EMT); EPITHELIAL-MESENCHYMAL TRANSITION; ANTIANGIOGENIC THERAPY; MICROVESSEL DENSITY; METASTASIS; SORAFENIB; ANGIOGENESIS; BEVACIZUMAB; PREDICTOR; INVASION; PLUS;
D O I
10.1016/j.jhepr.2023.100792
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Vessels that encapsulate tumour clusters (VETC) is a distinct histologic vascular pattern associated with a novel mechanism of metastasis. First described in human cancers in 2004, its prevalence and prognostic significance in hepatocellular carcinoma (HCC) has only been appreciated in the past decade with a rapidly increasing body of literature. A robust biomarker of aggressive disease, the VETC pattern is easy to recognise but relies on histologic examination of tumour tissue for its diagnosis. Radiological recognition of the VETC pattern is an area of active research and is becoming increasingly accurate. As a prognostic marker, VETC has consistently proven to be an independent predictor of disease recurrence and overall survival in patients with HCC undergoing resection and liver transplantation. It can also guide treatment by predicting response to other therapies such as transarterial chemoembolisation and sorafenib. Without prospective randomised-controlled trials or routine evaluation of VETC in clinical practice, there are currently no firm treatment recommendations for VETC-positive tumours, although some perspectives are provided in this review based on the latest knowledge of their pathogenesis - a complex interplay between tumour angiogenesis and the immune microenvironment. Nevertheless, VETC has great potential as a future biomarker that could take us one step closer to precision medicine for HCC. & COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma
    Tang, Decai
    Zhang, Shuo
    Shi, Xiaoxia
    Wu, Jiafei
    Yin, Gang
    Tan, Xiying
    Liu, Fuyan
    Wu, Xingdong
    Du, Xiangyu
    INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [22] Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma
    Cros, Jerome
    Sbidian, Emilie
    Posseme, Katia
    Letierce, Alexia
    Guettier, Catherine
    Benoit, Gerard
    Ferlicot, Sophie
    VIRCHOWS ARCHIV, 2016, 469 (03) : 331 - 337
  • [23] The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Wang, Miaomiao
    Cao, Liang
    Wang, Yinzhong
    Huang, Hongliang
    Tian, Xiaoxue
    Lei, Junqiang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08) : 2037 - 2046
  • [24] Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma
    Bagi, Cedo Martin
    Gebhard, David F.
    Andresen, Catharine J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (05) : 563 - 574
  • [25] Preoperative MRI features for characterization of vessels encapsulating tumor clusters and microvascular invasion in hepatocellular carcinoma
    Yang, Jiawen
    Dong, Xue
    Wang, Guanliang
    Chen, Jinyao
    Zhang, Binhao
    Pan, Wenting
    Zhang, Huangqi
    Jin, Shengze
    Ji, Wenbin
    ABDOMINAL RADIOLOGY, 2023, 48 (02) : 554 - 566
  • [26] LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
    Shao, Bing
    Zhao, Xiulan
    Liu, Tieju
    Zhang, Yanhui
    Sun, Ran
    Dong, Xueyi
    Liu, Fang
    Zhao, Nan
    Zhang, Danfang
    Wu, Lili
    Wang, Yong
    Wang, Meili
    Meng, Jie
    Lin, Xian
    Sun, Baocun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (02) : 1363 - 1374
  • [27] Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling
    Berge, Mathieu
    Allanic, David
    Bonnin, Philippe
    de Montrion, Catherine
    Richard, Johann
    Suc, Michel
    Boivin, Jean-Francois
    Contreres, Jean-Olivier
    Lockhart, Brian P.
    Pocard, Marc
    Levy, Bernard I.
    Tucker, Gordon C.
    Tobelem, Gerard
    Merkulova-Rainon, Tatyana
    JOURNAL OF HEPATOLOGY, 2011, 55 (04) : 866 - 875
  • [28] Targeting vessels to treat hepatocellular carcinoma
    Romanque, Pamela
    Piguet, Anne-Christine
    Dufour, Jean-Francois
    CLINICAL SCIENCE, 2008, 114 (7-8) : 467 - 477
  • [29] Nomogram prediction of vessels encapsulating tumor clusters in small hepatocellular carcinoma ≤ 3 cm based on enhanced magnetic resonance imaging
    Chen, Hui-Lin
    He, Rui-Lin
    Gu, Meng-Ting
    Zhao, Xing-Yu
    Song, Kai-Rong
    Zou, Wen-Jie
    Jia, Ning-Yang
    Liu, Wan-Min
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (05) : 1808 - 1820
  • [30] Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1
    Mao, Dengxuan
    Wang, Hong
    Guo, Hong
    Che, Xiaoyu
    Chen, Miaoying
    Li, Xia
    Liu, Yuping
    Huo, Jiege
    Chen, Yan
    PHYTOMEDICINE, 2024, 123